July 17, 2026: Joint Statement by CPE & EAA on the JCA reports for Lurbinectedin & Tarlatamab

June 18 & 19, 2026: Two days on Health Policy and EU HTA in the global context, organised by the University of Strasbourg

June 16, 2026: Joint Statement by CPE & EAA on the first JCA report (Tovorafenib)

December 11, 2025: A Pulse Check on EU HTA - Status at the End of Year One

December 8, 2025: EAA Comment on Risk of Type 2 Error in IQWiG's Assessment of Lecanemab

December 4, 2025: EAA Comment on HTACG Annual Work Programme for 2026

November 27, 2025: Memorial Symposium for Prof. Dr. Friedrich Wilhelm Schwartz, the "father of public health in Germany"

July 1st & 2nd, 2025: DG Santé Events on EU HTA in Brussels

The EAA would like to commend Maya Matthews and DG Santé for organizing exciting days on EU HTA in Brussels.

June 23, 2025: EAA Presentations at API-CCS event in Paris

Download the slides that were presented by the EAA Secretariat:

November 25, 2024: Open Letter from the EAA Faculty to the HTACG and DG Santé on the EU HTA Methods Guidance Documents

November 19, 2024: EAA Faculty Feedback on the Draft Implementing Act on JSC for Medical Devices

October 22, 2024: EAA Faculty Feedback on the Draft Implementing Act on JSC

June 25, 2024: EAA Faculty Feedback on the Draft Implementing Act on CoI

June 19, 2024: EAA Presentation at HTAi in Sevilla, Spain

April 14, 2024: EAA Faculty Statement on HTA CG Methodological Guideline for Treatment Comparisons

April 2, 2024: EAA Faculty Feedback on the Draft Implementing Act on JCA

Feb 19, 2024: EAA Post: 'Uncertainty - Friend or Foe'

Feb 06, 2024: EAA Post regarding 'Roadblocks' for EU HTA

Jan 15, 2024: EAA Post regarding the EU HTA Implementing Acts